Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Guggenheim

Eyewash, irreverence and a Bruce Springsteen concert: on the road with a pioneering performance poet

The Tour is Pi O’s verse diary about a small group of Australian poets who take their wares on the road in North America in the mid-1980s, sponsored by the Literature Board and the Guggenheim Foundation. This came to be known as “The Dirty T-Shirt Tour”, because Pi O’s dress…

The Conversation

'Real joy' to be had viewing Kandinsky's art in Sydney

New York's famed Guggenheim Museum has lent key paintings by Vasily Kandinsky to the Art Gallery of NSW for a major exhibition.

AAP

Tesla Deliveries Hit Record 466,140 EVs In Q2; TSLA Stock Jumps

Tesla deliveries easily beat second-quarter views, though production exceeded sales once again. TSLA stock, already more than doubling in 2023,, jumped Monday.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

‘She should be up there with the greatest’: celebrating the art of Gego

Fleeing Nazi Germany and ending up in Venezuela, the unusual artist found a career crafting offbeat sculptures, on display in a new exhibition

The Guardian - US

'Bilbao is full of culture, ludicrously cheap wine and delicious pintxos'

The Guggenheim museum in Bilbao has just celebrated its 25th birthday and, encased as it is in more than 30,000 titanium sheets and is fronted by artist Jeff Koons’ 39ft-high Puppy, it is still quite the landmark

Daily Mirror

'All the Beauty and the Bloodshed' chronicles Nan Goldin's career of art and activism

Filmmaker Laura Poitras and Goldin discuss their Oscar-nominated documentary about efforts to remove the Sackler family name from prominent museums amid the opioid epidemic.

WEKU

Artist Nan Goldin on addiction and taking on the Sackler dynasty: ‘I wanted to tell my truth’

Her battle against the billionaires who fuelled the opioid epidemic upended the art establishment. As a film about her life is released, she talks about family tragedy and her journey to activism

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Upgrades

Benzinga

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022

Upgrades

Benzinga

Etsy Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Etsy. Looking at options history for Etsy (NASDAQ:ETSY) we detected 27 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022

Upgrades

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Women artists: the belated craze for blockbuster shows is welcome – but it's not enough

The Barbican’s boldly curated exhibiton of abstract expressionist Lee Krasner (1908-1984) – who was routinely referred to as Jackson Pollock’s wife, despite being a well-established artist long before meeting him – transferred to the Guggenheim Bilbao in 2018. Before it opened, a Spanish newspaper invited me to introduce this “little…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Upgrades

The Independent UK

Laura Poitras film spotlights activist photographer Goldin

Laura Poitras' Nan Goldin documentary "All the Beauty and the Bloodshed,” is having its world premiere at the Venice Film Festival on Saturday, where it is part of the main competition slate

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

5 Kohl's Analysts On Bloated Inventory, Guidance Cut: 'Fundamentals Are Likely To Get Worse'

Kohl's Corporation (NYSE: KSS) shares are down 4% on Friday after the company cut its guidance and said inflation is eating into its sales growth.

Tribune News Service

Minneapolis-published Ada Limón is named US Poet Laureate

The Guggenheim fellow has published four books of poetry with Minneapolis' Milkweed Editions.

Benzinga

Read How Analysts Reacted To Kohl's Conclusion Of Strategic Review Process

Telsey Advisory Group analyst Dana Telsey has lowered the price target on Kohl's Corp (NYSE:KSS) to $35 (19% upside) from $55 and kept the Market Perform rating on the shares. Kohl's abandoned its negotiations with Franchise Group, considering the challenges in the current retail and financing environment. Also, the retail chain has cut its Q2 sales guidance on ongoing inflationary…

Daily Mirror

New Chelsea owner Todd Boehly - how rich is he and how did he make his money?

Todd Boehly is to be the new face of Chelsea Football Club, as his consortium secures permission to complete the sale of the west London outfit from Roman Abramovic after he bought it in 2003

The Guardian - UK

Todd Boehly’s vision for Chelsea? Glossy spectacle and ruthless profit

Judging by his time with the Los Angeles Dodgers, Boehly will sanction big spending as long as he sees even bigger returns

Benzinga

SVB Sees De-Risked Opportunity For This Newly Listed Norovirus Vaccine

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity. It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted). The outlook is supported by…

Benzinga

Guggenheim Maintains Buy Rating for Meta Platforms: Here's What You Need To Know

Guggenheim has decided to maintain its Buy rating of Meta Platforms (NASDAQ:FB) and lower its price target from $275.00 to $250.00. Shares of Meta Platforms are trading down 2.94% over the last 24 hours, at $196.67 per share.

1 2 3

People

Artemisia Gentileschi

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations